|
This CME activity has expired. CME credit is no longer available for this activity. However, the content will remain posted for your viewing convenience. |
FINANCIAL SUPPORT
This CME activity is cosponsored by the EOCME and Excerpta Medica and supported by an educational grant from sanofi-aventis U.S.
|
CONTENT DEVELOPMENT COMMITTEE |
|
Deepak L. Bhatt, MD
Geno J. Merli, MD
Michel M. Murr, MD
Mark J. Flanick, MS |
|
UNAPPROVED USE DISCLOSURE |
|
The EOCME requires CME faculty (speakers) to disclose to the attendees:
- When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and
- Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.
|
GOAL OF THE ACTIVITY |
|
Through completion of this activity, participants will become familiar with practical aspects related to clinical management of venous thromboembolism (VTE) and recognize how to reduce the risk of morbidity and mortality associated with VTE in obese patients. |
|
INTENDED AUDIENCE |
|
This activity is intended for surgeons, critical care physicians, cardiologists, general practice and internal medicine physicians and healthcare providers who treat postoperative patient populations who are at higher risk of thromboembolic complications due to obesity. |
|
INFORMATION ON CME CREDIT |
|
The EOCME designates this educational activity for a maximum of 0.5 category 1 credit toward the American Medical Association (AMA) Physician’s Recognition Award (PRA). Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
|
FACULTY DISCLOSURES |
|
In accordance with the ACCME Standards and the policy of the EOCME, the following faculty have indicated that they have a relationship which, in the context of their presentation, could be perceived as a real or apparent conflict of interest, but do not consider that it will influence their presentation. The nature of the conflict is listed.
| Faculty Member |
|
Manufacturer |
|
Relationship |
| Michel M.Murr, MD |
|
None |
|
None |
| Geno J. Merli, MD |
|
AstraZeneca, The sanofi-aventis Group |
|
Grants/Research Support, Consultant, Speaker’s Bureau |
|
|
Bacchus Vascular, Inc. |
|
Consultant |
|
|
Bayer Pharmaceuticals Corporation |
|
Grants/Research Support |
| Deepak L. Bhatt, MD |
|
Bristol-Myers Squibb Company, The sanofi-aventis Group |
|
Grants/Research Support |
|
ACCREDITATION STATEMENT |
|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Elsevier Office of Continuing Medical Education (EOCME) and Excerpta Medica, Inc. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians. |
|
EDUCATIONAL OBJECTIVES |
|
Upon completion of this activity, participants will be able to:
- Risk stratify acute coronary syndromes
- Implement a protocol for diagnosis of non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction
- Explain the rationale for necessity of hospital treatment guidelines in patients with unstable angina/non-ST-elevation myocardial infarction
This activity may contain references to off-label/unapproved uses of drugs or medical devices. Please consult the product prescribing information for full disclosure of labeled uses. |
|
HARDWARE AND SOFTWARE SPECIFICATIONS NEEDED TO VIEW SITE |
|
This course requires Windows Operating Systems (95/98, NT, 2000, ME, XP), version 5.5 browsers or higher from Microsoft or Netscape.
Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
|
|
DATE AND TIME INFORMATION |
|
Case studies in thromboembolic disease: prophylaxis of VTE in the obese patient, presented by Michel M. Murr, MD, Associate Professor of Surgery, University of South Florida, Sarasota, Florida.
Release date: August 20, 2005
Expiration date: August 20, 2007
Estimated time to complete activity: 0.5 hour
On completion of this activity, to obtain AMA PRA category 1 credit, participants must complete the post-test and evaluation form. This can be completed on-line, or should you prefer to complete the form off-line, print and mail/fax the hard copy to:
Elsevier Office of Continuing Medical Education
Department TC-PVTEOP
685 Route 202/206
Bridgewater, NJ 08807
or e-mail us at tc-pvteop@elsevier.com
There is no fee for participants who apply for CME credit for this activity.
Responses must be submitted by May 20, 2007.
|
|
| | |